Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells (Q34487820)

2 August 2017

Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells (English)

1 reference

2 August 2017

1 reference

Gong J

1

1 reference

2 August 2017

Zhu J

2

1 reference

2 August 2017

Goodman OB Jr

3

1 reference

2 August 2017

Pestell RG

4

1 reference

2 August 2017

Schlegel PN

5

1 reference

2 August 2017

Nanus DM

6

1 reference

2 August 2017

Shen R

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

2 August 2017

1 reference

2 August 2017

25

1 reference

2 August 2017

14

1 reference

2 August 2017

2011-2021

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209231

2 August 2017

0 references

cites work

Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Absence of p300 gene promoter methylation in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Androgen receptors in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

p300 modulates nuclear morphology in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Acetylation in hormone signaling and the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Acetylation of nuclear receptors in cellular growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

p300 and CBP: partners for life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Androgen receptor (AR) coregulators: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Prostate cancer: molecular biology of early progression to androgen independence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Identification and characterization of two androgen response regions in the human neutral endopeptidase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

CREB-binding protein and p300 in transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Mutations truncating the EP300 acetylase in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

Bombesin stimulates growth of human prostatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Phorbol ester causes ligand-independent activation of the androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Selective activation of the probasin androgen-responsive region by steroid hormones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Nuclear receptor coregulators: cellular and molecular biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Phosphorylation of p300 at serine 89 by protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Inhibition of histone acetyltransferase function of p300 by PKCdelta.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209231

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209231

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference